Clinical Trial Update: Tusamitamab Ravtansine Monotherapy and in Combination in Patients With CEACAM5-positive Advanced Solid Tumors [Phase 2]

View source ↗

Summary

Phase 2 study of tusamitamab ravtansine as monotherapy and in combination for CEACAM5-positive advanced solid tumors (metastatic breast cancer and metastatic pa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Pancreatic Cancer

Drugs mentioned

• Tusamitamab Ravtansine (Tusamitamab Ravtansine)

Snippet

Sponsor: Sanofi | Conditions: Breast Cancer Metastatic, Pancreatic Carcinoma Metastatic | Phase 2 | Status: TERMINATED | Results posted: 2025-03-25